Abstract
AbstractLong COVID, characterized by persistent symptoms following acute infection, poses a significant health challenge, particularly for patients with pre-existing chronic conditions such as hypertension. We hypothesized that an increase in the production of interleukins (IL)-6 and IL-17 could serve as a potential mechanism linking pre-existing uncontrolled blood pressure (BP) to the occurrence of long-term COVID sequelae in patients undergoing hemodialysis (HD). This cross-sectional study examined serum IL-6 and IL-17 levels in 80 patients undergoing HD, considering preinfection BP, the presence of long-term COVID sequelae, and the time interval after acute COVID-19 infection, which was either 5 or 10 months. Controlled BP was defined as a 3-month average pre-dialysis BP < 140/90 mmHg and post-dialysis < 130/80 mmHg. The findings suggest that the prevalence of long-term COVID sequelae was significantly higher in patients with uncontrolled BP than in the BP-controlled group. Both IL-6 and IL-17 concentrations were also significantly higher in patients with uncontrolled BP compared with the BP-controlled group. The patients with long-term COVID sequelae had higher IL-6 and IL-17 values than the fully recovered patients at both time points, but their concentrations decreased significantly over time. Further research and prospective studies are warranted to validate these findings.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Wang, F. et al. Risk factors for mortality in hemodialysis patients with COVID-19: A systematic review and meta-analysis. Ren. fail. 43, 1394–1407 (2021).
2. Hsu, C. M. et al. COVID-19 among US dialysis patients: Risk factors and outcomes from a national dialysis provider. Am. J. Kidney. Dis. 77, 748-756.e1 (2021).
3. Ozturk, S. et al. The longitudinal evolution of post-COVID-19 outcomes among hemodialysis patients in Turkey. Kidney Int. Rep. 7, 1393–1405 (2022).
4. Och, A. et al. Persistent post-COVID-19 syndrome in hemodialyzed patients-A longitudinal cohort study from the north of Poland. J. Clin. Med. 10, 4451. https://doi.org/10.3390/jcm10194451 (2022).
5. Stepanova, N. et al. High-density lipoproteins and clinical outcomes of COVID-19 in hemodialysis patients: A multicenter, propensity-score matched case-control study. Ukr. J. Nephrol. Dial. 73, 22–30 (2022).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献